Results
1 -
10 of
10
(Click
here to explore results)
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612
- Materials engineering strategies for cancer vaccine adjuvant development. Xuanbo Zhang, Bowei Yang, Qianqian Ni, Xiaoyuan Chen
, Chem. Soc. Rev.
, 2023
, 52
, 2886
- Small molecule modulators of immune pattern recognition receptors. Taku Tsukidate, Charles W. Hespen, Howard C. Hang
, RSC Chem. Biol.
, 2023
, 4
, 1014
- Targeting the innate immune system with nanoparticles for cancer immunotherapy. Kai Li, Zhicheng Zhang, Yu Mei, Mengmeng Li, Qingzhu Yang, Qiong Wu, Huanjie Yang, Liangcan He, Shaoqin Liu
, J. Mater. Chem. B
, 2022
, 10
, 1709
- Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment. Jitender Bariwal, Hairong Ma, Guillermo A. Altenberg, Hongjun Liang
, Chem. Soc. Rev.
, 2022
, 51
, 1702
- Liposomes modified with bio-substances for cancer treatment. Yanan Li, Hailin Cong, Song Wang, Bing Yu, Youqing Shen
, Biomater. Sci.
, 2020
, 8
, 6442
- Pharmaceutical liposomal delivery—specific considerations of innovation and challenges. Taoxing Peng, Weihua Xu, Qianqian Li, Yang Ding, Yongzhuo Huang
, Biomater. Sci.
, 2023
, 11
, 62
- Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. M. Joyce Nirmala, Uma Kizhuveetil, Athira Johnson, Balaji G, Ramamurthy Nagarajan, Vignesh Muthuvijayan
, RSC Adv.
, 2023
, 13
, 8606
- Lipid-based nanovesicles for nanomedicine. N. Grimaldi, F. Andrade, N. Segovia, L. Ferrer-Tasies, S. Sala, J. Veciana, N. Ventosa
, Chem. Soc. Rev.
, 2016
, 45
, 6520
- Organic and inorganic nanomedicine for combination cancer therapies. Donghyun Lee, Jeongsu Shin, Hangyu Son, Seo Young Cheon, Yeeun Lee, Joonhyuck Park, Heebeom Koo
, Nanoscale Adv.
, 2023
, 5
, 1600